Publications

ORCiD: https://orcid.org/0000-0002-3278-5071
*Equal contribution 
Newest listed first.

Preprints

  • Vanderbeek AM, Sabbaghi A, Walsh JR, Fisher CK. “Bayesian Prognostic Covariate Adjustment with Additive Mixture Priors”. arXiv. February 2024. 
  • Vanderbeek AM, Vidovsky AA, Ross JL, Sabbaghi A, Walsh JR, Fisher CK. “A Weighted Prognostic Covariate Adjustment Method for Efficient and Powerful Treatment Effect Inferences in Randomized Controlled Trials” arXiv. September 2023.
  • Vanderbeek AM, Ross JL, Miller DP, Schuler A. “Prognostic Covariate Adjustment for Binary Outcomes Using Stratification”. arXiv. Dec 2022.

Peer-reviewed papers

First-author papers

  1. Vanderbeek AM*, Redd R*, Ventz S, Trippa L. “Looking ahead in early-phase trial design to improve the drug development process: examples in oncology”. BMC Medical Research Methodology. June 2023.
  2. Vanderbeek AM, Bliss JM, Yin Z, Yap C. “Implementation of platform trials in the COVID-19 pandemic: a rapid review”. Contemporary Clinical Trials. November 2021.
  3. Vanderbeek AM*, Ventz S*, Rahman R, Fell G, Trippa L, Alexander BM. To randomize, or not to randomize, that is the question: using data from prior clinical trials to guide future designs. Neuro-Oncology. May 2019.
  4. Vanderbeek AM, Rahman R, Fell G, Ventz S, Chen T, Redd R, Parmigiani G, Cloughesy T, Wen P, Trippa L, Alexander BM. The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?  Neuro-Oncology. April 2018.

All papers

  1. Vanderbeek AM*, Redd R*, Ventz S, Trippa L. “Looking ahead in early-phase trial design to improve the drug development process: examples in oncology”. BMC Medical Research Methodology. June 2023.
  2. Pownder SL, Neri JP, Hayashi K, Vanderbeek AM, Koff MF. “Age and Sex Comparison of the Canine Supraspinatus Tendon Using Quantitative Magnetic Resonance Imaging T2 Mapping”. Veterinary and Comparative Orthopaedics and Traumatology. February 2022.
  3. Lai-Kwon JE, Vanderbeek AM, Minchom A, Lee OA, Ogunleye D, Stephens R, Calvert M, Yap C. ” Stakeholder Perspectives on the use of Patient-Reported Outcomes in Early Phase, Dose Finding Oncology Trials: Surveys of International Clinical Trialists and members of the National Cancer Research Institute Consumer Forum. The Oncologist. June 2022.
  4. Tan ET, Serrano KC, Bhatti P, Pishgar F, Vanderbeek AM, Milani CJ, Sneag DB. “Quantitative MRI Differentiates Electromyography Severity Grades of the Denervated Muscle in Neuropathy of the Brachial Plexus”. Journal of Magnetic Resonance Imaging. February 2022.
  5. Vanderbeek AM, Bliss JM, Yin Z, Yap C. “Implementation of platform trials in the COVID-19 pandemic: a rapid review”. Contemporary Clinical Trials. November 2021.
  6. Shea S, Thompson JLP, Schwartz J, Chen Y, de Ferrante M, Vanderbeek AM, Buchsbaum R, Celibell V, Siddiqui KM, Moran AE, Stockwell M. The Retail Outlet Health Kiosk Hypertension Trial (ROKHYT): Pilot Results, American Journal of Hypertension. August 2021.
  7. Fell G*, Redd R*, Vanderbeek AM, Rahman R, Arfè A, Alexander BM, Ventz S, Trippa L. KMDATA: A Curated Database of Reconstructed Individual Patient Level Data from 153 Oncology Clinical trials. DATABASE. May 2021. 
  8. Rahman R, Fell G, Ventz S, Arfe A, Vanderbeek AM, Trippa L, Alexander BM. Deviation from the proportional hazards assumption in randomized phase 3 oncology clinical trials: prevalence, associations, and implications. Clinical Cancer Research. July 2019.
  9. Vanderbeek AM*, Ventz S*, Rahman R, Fell G, Trippa L, Alexander BM. To randomize, or not to randomize, that is the question: using data from prior clinical trials to guide future designs. Neuro-Oncology. May 2019.
  10. Rahman R, Ventz S, Fell G, Vanderbeek AM, Trippa L, Alexander BM. Divining Responder Populations from Survival Data. Annals of Oncology. March 2019.
  11. Vanderbeek AM, Rahman R, Fell G, Ventz S, Chen T, Redd R, Parmigiani G, Cloughesy T, Wen P, Trippa L, Alexander BM. The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?  Neuro-Oncology. April 2018.